Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T36404 |
PRLX-93936
|
||
PRLX-93936 is an analog of erastin that has antitumor activity. It inhibits the hypoxia-inducible factor 1 (HIF-1) signaling pathway under hypoxic conditions (IC50 = 0.09 μM in a cell-based reporter assay). PRLX-93936 (1 μM) also inhibits hypoxia-induced increases in HIF-1α expression in ME-180 cervical cancer cells. It inhibits the growth of HT-1080 fibrosarcoma, OVCAR-5 ovarian cancer, BJELR tumorigenic primary fibroblast, and PANC-1 pancreatic cancer cells with IC50 values of less than 100 nM... | |||
T36404L |
PRLX-93936 HCL
PRLX-93936 hcl(903499-49-0 Free base) |
Ferroptosis; Reactive Oxygen Species | Apoptosis; Immunology/Inflammation; Metabolism; NF-κB |
PRLX-93936 HCL 是 erastin 的类似物,并显示出与顺铂对非小细胞肺癌 (NSCLC) 细胞的协同作用。 |